Indefinite Delivery Contract SPE2D021D0008

Award Date 9/28/21
Last Date to Order 9/27/31
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
American Regent Inc., a pharmaceutical manufacturer and distributor, holds two major federal contract vehicles with the U.S. government. The first is a $131.4 million multiple award Federal Supply Schedule contract with the Department of Veterans Affairs to supply hematology-related pharmaceutical products to VA health centers across 10 states through September 2028. The second is a $13.8 million single award indefinite delivery/indefinite quantity (IDIQ) contract with the Defense Logistics...
The Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) awards American Regent Inc., a pharmaceutical manufacturer and distributor, a $131.4 million multiple award contract to supply hematology-related pharmaceutical products to VA health centers across ten states over a five-year period from September 2023 to September 2028. American Regent Inc. also holds a $13.8 million single award indefinite delivery/indefinite quantity (IDIQ) contract with the Defense...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Under this contract, the DLA issues numerous delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract serves as the primary vehicle for Amerisourcebergen to deliver specialty medications, brand-name and generic drugs, vaccines, syringes,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp's Corporate Office Division worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Under this contract, Amerisourcebergen provides specialty,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of pharmaceutical products and medical supplies to support various government agencies and healthcare programs. The single-award IDC, valued at up to $999,999,999 through December 2025, enables the DLA to efficiently procure essential medical commodities such as specialty medications, brand-name...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide. This IDC serves as the primary vehicle for Amerisourcebergen to efficiently deliver essential pharmaceutical products, medical supplies, and equipment to the...
The Defense Logistics Agency (DLA) has awarded an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 to Amerisourcebergen Drug Corp for the delivery of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of November 30, 2026. As a major pharmaceutical distributor, Amerisourcebergen will leverage its extensive supply chain network to provide a wide array of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) worth up to $999,999,999 to Amerisourcebergen Drug Corp through December 2026. This single-award IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract covers the delivery of specialty medications, brand-name and generic drugs, vaccines, medical...
The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $999,999,999 single-award contract, which has a period of performance through December 31, 2025, is to provide pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities and programs. As the prime contractor, Amerisourcebergen Drug Corp will deliver a...
  • SPE2D021D0008
    Indefinite Delivery Contract
  • 100
    Federal Contract Awards

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13.8 million single-award indefinite delivery/indefinite quantity (IDIQ) contract to American Regent Inc., a pharmaceutical manufacturer and distributor, to provide various pharmaceuticals to support military medical treatment facilities worldwide. The contract, which runs through September 2031, enables American Regent to deliver critical injectable medications, including atropine sulfate, glycopyrrolate, and hydroxyzine, through firm-fixed-price delivery orders. American Regent also holds a $131.4 million multiple award Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs to supply hematology-related pharmaceutical products. The DLA contract does not have any set-aside designations, indicating American Regent's ability to compete in full and open competition. The company specializes in injectable drugs and sterile pharmaceutical preparations, and has consistently supplied essential medications to the U.S. government through various federal contract vehicles.

The task orders issued under the DLA IDIQ contract demonstrate American Regent's role in providing a range of pharmaceutical products to military healthcare programs. Delivery orders have primarily focused on the supply of injectable medications such as atropine sulfate, glycopyrrolate, and hydroxyzine, with the majority of the deliveries being made from the company's facility in East Yaphank, New York. These firm-fixed-price contracts, typically ranging from a few hundred to tens of thousands of dollars, support the DLA Troop Support Medical's mission to maintain medical readiness and deliver critical pharmaceuticals to military medical treatment facilities worldwide.

Generated 3/20/25, 9:49 AM